Asian Markets Rise Amid US-Iran Talks & Middle East Conflict
- Asian equity markets are poised for modest gains Thursday, buoyed by a cautiously optimistic response to ongoing efforts to de-escalate conflict in the Middle East.
- Futures contracts indicate a positive open for Japan and Australia, while Hong Kong futures are slightly lower.
- The market’s reaction comes as the US and Iran navigate a complex diplomatic landscape.
Asian Markets Respond to Tentative US-Iran Ceasefire Talks
Asian equity markets are poised for modest gains Thursday, buoyed by a cautiously optimistic response to ongoing efforts to de-escalate conflict in the Middle East. The gains follow a positive session for US stocks and bonds, as traders assess the viability of a 15-point US peace plan presented to Iran.
Futures contracts indicate a positive open for Japan and Australia, while Hong Kong futures are slightly lower. The S&P 500 and Nasdaq 100 both advanced Wednesday, gaining 0.5% and 0.7% respectively, extending a two-day rally. A gauge of US-listed Chinese companies saw a more substantial increase, rising 1.9%. This resilience in equity markets suggests investors are increasingly pricing in a potential resolution, despite continued uncertainty.
The market’s reaction comes as the US and Iran navigate a complex diplomatic landscape. While the White House reports “productive talks” over the past three days, with a proposed framework for Iran to dismantle its nuclear facilities and limit its missile arsenal, Tehran has signaled resistance. Semi-official Fars news agency reported that indirect talks initiated by the US are “illogical and not viable” at this stage. Iran is reportedly demanding guarantees against future attacks from the US and Israel, as well as reparations for damages and recognition of its authority over the Strait of Hormuz.
The initial market surge earlier in the week, triggered by reports Iran would allow “non-hostile” ships through the Strait of Hormuz, has tempered somewhat. Oil prices, which had fallen by 4% on Wednesday, edged higher Thursday, hovering around $91 a barrel. This volatility underscores the sensitivity of energy markets to geopolitical developments in the region. Brent crude briefly dipped below $100 a barrel before recovering slightly, reflecting the mixed signals emanating from negotiations.
The conflict’s impact extends beyond financial markets. Several Asian nations are actively preparing for potential disruptions. South Korea has established an emergency task force, Japan is reviewing its petroleum supply chain and the Philippines has declared a national emergency. These measures highlight the broader regional concerns stemming from the instability in the Middle East.
Despite the cautious optimism, analysts warn against complacency. “There’s really no way to know at this point what the facts are regarding the state of negotiations, so expect more whipsaw action as things continue to progress,” strategists at Bespoke Investment Group noted. The balance of power remains tilted against Iran, but its response to US de-escalation efforts will be crucial in determining whether the peak of market fear has passed.
Looking ahead, investors will be closely monitoring economic data releases across Asia, including producer prices in Japan, industrial production in Singapore, and unemployment figures for Taiwan. The meeting of G7 foreign ministers in France will also be a key event to watch, as international pressure mounts for a peaceful resolution.
Beyond the immediate geopolitical concerns, the strength of corporate earnings is providing a degree of support to equity markets. Analysts estimate S&P 500 companies will achieve an 11.9% profit growth in the first quarter, a slight increase from pre-war forecasts. This suggests that, even amidst global uncertainty, the underlying fundamentals of the US economy remain relatively robust.
Recent corporate activity also reflects a degree of confidence. Arm Holdings Plc announced plans to sell its own chips, a move expected to generate $15 billion in annual revenue. Merck & Co. Agreed to acquire Terns Pharmaceuticals Inc. For $6.7 billion, bolstering its pipeline of leukemia treatments. These deals indicate that companies are continuing to invest in long-term growth, despite the current geopolitical climate.
